Some studies have reported that IL-6 levels are higher in neutropenic CRC patients with advanced clinical staging, suggesting that IL-6 may be closely related to the altered biological properties of colorectal tumor cells (49). This evidence concerns the gene IL6 and colorectal neoplasm.